BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36972534)

  • 1. Adaptation and Content Validation of a Patient-Reported Measure of Treatment Burden for use in Stroke Survivors (PETS-Stroke).
    Gallacher K; Sardar A; Kidd L; Wood K; Mair F; Eton D; Quinn T
    Ann Fam Med; 2023 Jan; 21(21 Suppl 1):. PubMed ID: 36972534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation and content validation of a patient-reported measure of treatment burden for use in stroke survivors: the patient experience with treatment and self-management in stroke (PETS-stroke) measure.
    Wood K; Sardar A; Eton DT; Mair FS; Kidd L; Quinn TJ; Gallacher KI
    Disabil Rehabil; 2024 Jul; 46(14):3141-3150. PubMed ID: 37545161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deriving and validating a brief measure of treatment burden to assess person-centered healthcare quality in primary care: a multi-method study.
    Eton DT; Linzer M; Boehm DH; Vanderboom CE; Rogers EA; Frost MH; Wambua M; Vang M; Poplau S; Lee MK; Anderson RT
    BMC Fam Pract; 2020 Oct; 21(1):221. PubMed ID: 33115421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden.
    Eton DT; Yost KJ; Lai JS; Ridgeway JL; Egginton JS; Rosedahl JK; Linzer M; Boehm DH; Thakur A; Poplau S; Odell L; Montori VM; May CR; Anderson RT
    Qual Life Res; 2017 Feb; 26(2):489-503. PubMed ID: 27566732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The patient experience with treatment and self-management (PETS) questionnaire: translation and cultural adaption of the Norwegian version.
    Husebø AML; Morken IM; Eriksen KS; Nordfonn OK
    BMC Med Res Methodol; 2018 Nov; 18(1):147. PubMed ID: 30463519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Delphi methodology in the development of a new patient-reported outcome measure for stroke survivors with visual impairment.
    Hepworth LR; Rowe FJ
    Brain Behav; 2018 Feb; 8(2):e00898. PubMed ID: 29484260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment burden for people experiencing homelessness with a recent non-fatal overdose: a questionnaire study.
    Jones C; Mair FS; Williamson AE; McPherson A; Eton DT; Lowrie R
    Br J Gen Pract; 2023 Oct; 73(735):e728-e734. PubMed ID: 37429734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What helps and hinders the provision of healthcare that minimises treatment burden and maximises patient capacity? A qualitative study of stroke health professional perspectives.
    Kyle J; Skleparis D; Mair FS; Gallacher KI
    BMJ Open; 2020 Mar; 10(3):e034113. PubMed ID: 32193265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmatory Factor Analyses and Differential Item Functioning of the Patient Experience with Treatment and Self-Management (PETS vs. 2.0): A Measure of Treatment Burden.
    Lee MK; St Sauver JL; Anderson RT; Linzer M; Eton DT
    Patient Relat Outcome Meas; 2020; 11():249-263. PubMed ID: 33447118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a patient reported outcome measures for measuring the impact of visual impairment following stroke.
    Hepworth LR; Rowe FJ; Burnside G
    BMC Health Serv Res; 2019 May; 19(1):348. PubMed ID: 31151449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of patient-reported measures of treatment burden in stroke.
    Gallacher KI; Quinn T; Kidd L; Eton D; Dillon M; Elliot J; Johnston N; Erwin PJ; Mair F
    BMJ Open; 2019 Sep; 9(9):e029258. PubMed ID: 31533946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conceptual model of treatment burden and patient capacity in stroke.
    Gallacher KI; May CR; Langhorne P; Mair FS
    BMC Fam Pract; 2018 Jan; 19(1):9. PubMed ID: 29316892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Post Stroke Checklist: a pilot study in the United Kingdom and Singapore.
    Ward AB; Chen C; Norrving B; Gillard P; Walker MF; Blackburn S; Holloway L; Brainin M; Philp I;
    Int J Stroke; 2014 Oct; 9 Suppl A100():76-84. PubMed ID: 25088427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating the Patient Experience with Treatment and Self-Management (PETS), a patient-reported measure of treatment burden, in people with diabetes.
    Rogers EA; Yost KJ; Rosedahl JK; Linzer M; Boehm DH; Thakur A; Poplau S; Anderson RT; Eton DT
    Patient Relat Outcome Meas; 2017; 8():143-156. PubMed ID: 29184456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-management and self-efficacy in stroke survivors: validation of the Italian version of the Stroke Self-Efficacy Questionnaire.
    Dallolio L; Messina R; Calugi S; Fugazzaro S; Bardelli R; Rucci P; Fantini MP; Cavalli E; Taricco M;
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):68-74. PubMed ID: 27996219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a patient-centred, patient-reported outcome measure (PROM) for post-stroke cognitive rehabilitation: qualitative interviews with stroke survivors to inform design and content.
    Patchick EL; Horne M; Woodward-Nutt K; Vail A; Bowen A
    Health Expect; 2015 Dec; 18(6):3213-24. PubMed ID: 25483800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Known-groups validity and responsiveness to change of the Patient Experience with Treatment and Self-management (PETS vs. 2.0): a patient-reported measure of treatment burden.
    Eton DT; Lee MK; St Sauver JL; Anderson RT
    Qual Life Res; 2020 Nov; 29(11):3143-3154. PubMed ID: 32524346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Caregiver Burden Questionnaire for Heart Failure (CBQ-HF): face and content validity.
    Humphrey L; Kulich K; Deschaseaux C; Blackburn S; Maguire L; Strömberg A
    Health Qual Life Outcomes; 2013 May; 11():84. PubMed ID: 23706131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.